ArticleDiscover nano2026
Sensitivity analysis of microbial characteristics of trihybrid carreau nanofluid using response surface methodology and ANOVA.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study considers the sensitivity analysis of a trihybrid Carreau nanofluid by examining the transport and distribution of motile microorganisms within a suspension composed of titanium oxide, copper, and silver nanoparticles dispersed in sodium alginate as the base fluid. Sodium alginate is selected due to its shear-thinning rheological behavior, which is well represented by the Carreau fluid model. The nanofluid-microorganism mixture is assumed to flow over a nonlinearly stretched Riga surface under time-dependent stagnation-point conditions. The proposed model considers two-dimensional laminar flow in a porous medium, incorporating the effects of Newtonian heating, Stefan blowing, nonlinear thermal radiation, viscous dissipation, and chemical reactions. The governing partial differential equations (PDEs), derived from the fundamental conservation laws of mass, momentum, energy, nanoparticle concentration, and microorganism density, are transformed into a system of coupled nonlinear ordinary differential equations (ODEs) through appropriate similarity transformations. These equations are solved numerically using MATLAB's bvp4c algorithm. Furthermore, Response Surface Methodology (RSM) based on a Central Composite Design (CCD) is employed to optimize the velocity, thermal, solutal, and microbial transport characteristics. The combined effects of nanoparticle volume fractions (0.01-0.05) and unsteady parameters (0.1-0.6) on the Nusselt number, Sherwood number, and motile microorganism density factor are systematically examined. A sensitivity analysis is also conducted to assess the influence of nanoparticle loading on the microbial density response, highlighting the robustness and stability of the proposed microbial nanofluid system. The trihybrid nanofluid shows significantly improved thermal performance 24% and microbe's acclivity reduction 18% as compared to the conventional fluid. The statistical significance of the input factors is confirmed by an ANOVA (ANalysis Of Variance) with a model [Formula: see text] value of more than 99%. Findings indicate that silver nanoparticles improve velocity, temperature, concentration and microbial gradients with increased concentration of the silver nanoparticles because of the high thermal conductivity and bioactivity but titanium oxide has a high microbial impact. The trihybrid nanofluid displays much better thermal performance and microbial activity in comparison with conventional nanofluids and optimized configurations of nanofluids obtained with the help of RSM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.